Brad Smith, of Arizona, has become the first person with ALS to receive a brain implant from Neuralink as part of an ongoing clinical trial.

A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don't know what causes it.

And every 90 minutes, another life is lost to this devastating disease. ALS, or amyotrophic lateral sclerosis, is a fatal neurodegenerative disease that gradually robs individuals of their ability ...

Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Scientists say an extract of the ancient medicinal plant a shwagandha has shown promise as a potential treatment to slow the symptoms of amyotrophic lateral sclerosis, also known as motor neurone ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

Applegate went public with her multiple sclerosis diagnosis in 2021. She now co-hosts a podcast about life with MS, called “MeSsy,” alongside actor Jamie-Lynn Sigler. Sigler, best known for her role ...

Treatment for mitochondrial diseases within reach Date: April 9, 2025 Source: University of Gothenburg Summary: A medical breakthrough could result in the first treatment for rare but serious ...

It is in late-stage clinical development for the treatment of neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), progressive MS (multiple sclerosis), and DCM (degenerative ...